Evaluating an artificial intelligence (AI) communication platform for racial biases in information quality about prostate cancer (PCa) germline testing.

283 Background: Guidelines recommend germline testing in advanced prostate cancer (PCa) to inform treatment and familial cancer risk, but Black patients are less likely to complete testing than white patients. Artificial intelligence (AI) tools are increasingly used in pre-test counseling to support education, access, and equity, but remain unevaluated for racial bias, which is a known hazard in other clinical contexts. Methods: We adapted a secure UCSF-developed generative AI platform (“ProGene”) for PCa genetics education. ProGene was prompted with 7 frequently asked questions (FAQs): types of genetic testing and test results, personal benefits, familial benefits, drawbacks, logistics, costs, and privacy concerns. We asked each FAQ 9 times: 3 simulated patients with metastatic PCa (Black, non-Hispanic white, and race-agnostic), each in triplicate, for a total 63 questions. Two blinded reviewers assessed the 63 responses across 4 domains: 1) Comprehensiveness (mean, 0–100%) using an investigator-created rubric, 2) Accuracy (proportion, presence/absence of inaccuracies), 3) Readability (mean grade level) via SMOG and Flesch-Kincaid formulas, and 4) Actionability (mean, 0-100%) based on PEMAT. We used the two-sample t-test and Wilcoxon rank-sum test to compare continuous outcomes, and chi-squared test for categorical outcomes, between race subgroups and each FAQ. Results: Table 1 summarizes outcomes by race. For comprehensiveness, the mean score was 67% and did not vary by race. However, for FAQ 1 (types of genetic testing and test results), ProGene responses to the Black patient were less comprehensive than those to the race-agnostic patient (60% vs 93%; p < 0.01). Inaccuracies were present in 32% of responses (median 0 and range 0-5 inaccuracies per response), most often due to misstatements about sample collection and misleading cost/insurance information, and did not vary by race or FAQ. Mean readability was 10th (SMOG) and 13th grades (Flesch-Kincaid), and did not vary by race/FAQ. Mean actionability was 92% and did not vary by race/FAQ. Conclusions: We did not identify major racial biases in the quality of the AI communication platform’s responses to PCa germline testing questions. Overall actionability was high, comprehensiveness and accuracy were moderate, but readability was limited, presenting opportunities for improved prompt engineering, AI model updates, and human oversight. AI communication platforms are a promising tool to promote equity in PCa germline testing delivery, warranting continued refinement and evaluation. Evaluation of AI platform response quality by race. Quality domain Black Non-Hispanic white Race agnostic Comprehensiveness (%) 64% 63% 74% Inaccuracy rate (%) 24% 38% 33% Readability (grade level) 11 12 12 Actionability (%) 90% 92% 93%

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2025-10-01
DOI
https://doi.org/10.1200/op.2025.21.10_suppl.283
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating an artificial intelligence (AI) communication platform for racial biases in information quality about prostate cancer (PCa) germline testing.

Julian C. Hong, Hala T. Borno, Barry Tong, Johanna Balas et al.
JCO Oncology Practice
Artificial Intelligence in Healthcare and Education
article

Evaluating an artificial intelligence (AI) communication platform for racial biases in information quality about prostate cancer (PCa) germline testing.

Julian C. Hong, Hala T. Borno, Barry Tong, Johanna Balas, Daniel H. Kwon, Franklin W. Huang, Rahul Aggarwal, Nonna Shakhnazaryan, Lauren Bowling
article en

Abstract

283 Background: Guidelines recommend germline testing in advanced prostate cancer (PCa) to inform treatment and familial cancer risk, but Black patients are less likely to complete testing than white patients. Artificial intelligence (AI) tools are increasingly used in pre-test counseling to support education, access, and equity, but remain unevaluated for racial bias, which is a known hazard in other clinical contexts. Methods: We adapted a secure UCSF-developed generative AI platform (“ProGene”) for PCa genetics education. ProGene was prompted with 7 frequently asked questions (FAQs): types of genetic testing and test results, personal benefits, familial benefits, drawbacks, logistics, costs, and privacy concerns. We asked each FAQ 9 times: 3 simulated patients with metastatic PCa (Black, non-Hispanic white, and race-agnostic), each in triplicate, for a total 63 questions. Two blinded reviewers assessed the 63 responses across 4 domains: 1) Comprehensiveness (mean, 0–100%) using an investigator-created rubric, 2) Accuracy (proportion, presence/absence of inaccuracies), 3) Readability (mean grade level) via SMOG and Flesch-Kincaid formulas, and 4) Actionability (mean, 0-100%) based on PEMAT. We used the two-sample t-test and Wilcoxon rank-sum test to compare continuous outcomes, and chi-squared test for categorical outcomes, between race subgroups and each FAQ. Results: Table 1 summarizes outcomes by race. For comprehensiveness, the mean score was 67% and did not vary by race. However, for FAQ 1 (types of genetic testing and test results), ProGene responses to the Black patient were less comprehensive than those to the race-agnostic patient (60% vs 93%; p < 0.01). Inaccuracies were present in 32% of responses (median 0 and range 0-5 inaccuracies per response), most often due to misstatements about sample collection and misleading cost/insurance information, and did not vary by race or FAQ. Mean readability was 10th (SMOG) and 13th grades (Flesch-Kincaid), and did not vary by race/FAQ. Mean actionability was 92% and did not vary by race/FAQ. Conclusions: We did not identify major racial biases in the quality of the AI communication platform’s responses to PCa germline testing questions. Overall actionability was high, comprehensiveness and accuracy were moderate, but readability was limited, presenting opportunities for improved prompt engineering, AI model updates, and human oversight. AI communication platforms are a promising tool to promote equity in PCa germline testing delivery, warranting continued refinement and evaluation. Evaluation of AI platform response quality by race. Quality domain Black Non-Hispanic white Race agnostic Comprehensiveness (%) 64% 63% 74% Inaccuracy rate (%) 24% 38% 33% Readability (grade level) 11 12 12 Actionability (%) 90% 92% 93%

JCO Oncology PracticeVol. 21(10_suppl)
University of California, San Francisco (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), University of San Francisco (US)
Openalex Percentile: Top 79%
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.